Identification of dipyridamole-induced regional wail motion abnormalities by echocardiography has recently been proposed as an alternative diagnostic stress test for coronary artery disease. This study evaluates this new technique by comparing the results obtained (overall, regionally and by abnormality type) with those of thallium-201 myocardial imaging after dipyridamole stress in 25 patients.
Introduction
The versatility and clinical value of thallium-201 myocardial scintigraphy after dipyridamole infusion is now established in the diagnosis and assessment of patients with ischaemic heart disease."2 Dipyridamole results in an increase in coronary artery flow by coronary arteriolar vasodilatation. Thallium is distributed to the coronary vascular beds in relation to blood flow and taken up After dipyridamole administration, mean heart infusion is an rate rose (72 to 82 beats per minute; P < 0.01) but 2 to 3.9 An mean blood pressure of the group did not change one with a significantly (from 140/83 mmHg to 140/81 mmHg; ed to increase P > 0.1). Two patients, however, became symptofarcted areas matically hypotensive requiring dipyridamole I wall motion reversal with aminophylline.
Technically satisfactory stress thallium images The regional wall motion changes induced by dipyridamole are readily identified by echocardiography.4 6 The combination of dipyridamole and echocardiography, if clinically valuable, would provide a highly mobile, widely available, inexpensive and repeatable assessment of ischaemic heart Values indicate sensitivity, specificity and predictive value of DP-echo for DP-thallium.
group
disease. This study was undertaken therefore to evaluate dipyridamole-echocardiography by comparing it with dipyridamole-thallium imaging, another technique which assesses the functional significance of coronary artery lesions.
The patients in this study were typical of those with coronary artery disease in not being ideal echocardiographic subjects. They are predominantly in an older age group and smokers with chronic lung disease. Despite this, interpretable echocardiographic images could be obtained in all views in 80%. This suggests that most patients suspected of coronary artery disease would be suitable for this imaging technique.
The high concordance of the echocardiography with respect to thallium defects in both overall and regional analysis suggests that echocardiography is also an accurate predictor of coronary artery disease. We have found that for discordant results, it is sometimes the thallium and sometimes the echo that best compares with the presence of significant lesions at coronary angiography. The presence of significant atheroma does not necessarily imply a functional abnormality of course, and it is myocardial function that both these techniques assess. However, the angiographic data do suggest that the discordant results between the two techniques are not due to lesser accuracy of the echo but that they are each correct in different circumstances, possibly as they each assess different aspects of the functional consequences of coronary atheroma.
Previous studies of the dipyridamole-echocardiographic test define ischaemic segments as only those whose amplitude ofmovement reduces after dipyridamole stress, whereas Josephson and ourselves also include those segments which fail to increase their amplitude of movement. This wider definition increases the sensitivity of the technique with modest loss of specificity and is more suitable for the general assessment of patients with suspected coronary artery disease. In certain specific circumstances, however, such as assessing the functional significance of an arteriographic stenosis prior to angioplasty, the more stringent definition may be more appropriate.
When trying to distinguish ischaemic from infarcted myocardial segments, the sensitivity of the echocardiographic technique was poor. The definition used in this study required that initial wall motion be normal. However, some segments of viable muscle may be so compromised in their blood supply as to have a reduced amplitude of wall motion even at rest, so-called 'hibernating' myocardium. Such segments would be classified as infarcted by the terms of this study. This problem has not been addressed by studies to date. Further study is required to devise ways of identifying such segments without compromising the specificity of the diagnostic method.
This study demonstrates some clinical advantages of the dipyridamole-echocardiography as an alternative 'stress' test for coronary artery disease. It is both sensitive and specific, can be readily applied to the majority of patients and is less expensive than thallium imaging. The combination of the almost universal applicability of the dipyridamole 'stress' method and the convenience of echocardiography make dipyridamole-echocardiography a most valuable additional diagnostic aid in patients with suspected or proven coronary artery disease particularly in immobile patients and in centres without facilities for thallium scintigraphy.
